From the Journals

Advanced Primary Care program boosts COVID-19 results


 

FROM JAMA NETWORK OPEN

‘Innovative and important’

Renu Tipirneni, MD, an assistant professor of internal medicine at the University of Michigan and at the Institute for Healthcare Policy and Innovation in Ann Arbor, said Maryland is out front putting into practice what practices nationwide aspire to do – coordinating physical and mental health and social needs and integrating primary and public health. Dr. Tipirneni, who was not involved with the study, said she was impressed the researchers were able to show statistically significant improvement with COVID-19 outcomes in the first 2 years.

“In terms of health outcomes, we often have to wait longer to see good outcomes,” she said. “It’s a really innovative and important model.”

She said states can learn from each other and this model is an example.

Integrating primary care and public health and addressing social needs may be the biggest challenges for states, she said, as those realms typically have been siloed.

“But they may be the key components to achieving these outcomes,” she said.

Take-home message

The most important benefit of the program is that data suggest it saves lives, according to Dr. Haft. While the actual difference between COVID deaths in the program and nonprogram groups was small, multiplying that savings across the nation shows substantial potential benefit, he explained.

“At a time when we were losing lives at an unconscionable rate, we were able to make a difference in saving lives,” Dr. Haft said.

Authors report no relevant financial disclosures.

The study received financial support from the Maryland Department of Health.

Dr. Tiperneni is helping evaluate Michigan’s Medicaid contract.

Pages

Recommended Reading

Scientists use mRNA technology for universal flu vaccine
MDedge Internal Medicine
Cardiac injury caused by COVID-19 less common than thought
MDedge Internal Medicine
How to have a safer and more joyful holiday season
MDedge Internal Medicine
Endocarditis tied to drug use on the rise, spiked during COVID
MDedge Internal Medicine
Study of beliefs about what causes cancer sparks debate
MDedge Internal Medicine
SARS-CoV-2 seroprevalence grew rapidly in pandemic’s early waves
MDedge Internal Medicine
IBD patients have limited protection against Omicron with third vaccine dose
MDedge Internal Medicine
What’s next for COVID? Here’s what to know
MDedge Internal Medicine
Long COVID clinical trials may offer shortcut to new treatments
MDedge Internal Medicine
Gene associated with vision loss also linked to COVID: Study
MDedge Internal Medicine